VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection

Registros relacionados

• VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
  por: Midgley, R, et al.
  Publicado em: (2008)
• Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
  por: Midgley, R, et al.
  Publicado em: (2010)
• Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
  por: Kerr, D, et al.
  Publicado em: (2007)
• The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
  por: Huijbers, A, et al.
  Publicado em: (2013)
• The NSAID roller coaster: more about rofecoxib.
  por: Aronson, J
  Publicado em: (2006)